January 30, 2015 12:40 PM ET

Biotechnology

Company Overview of Prognomix, Inc.

Company Overview

Prognomix, Inc., a personalized medicine company, engages in the development of pre-symptomatic diagnostic tools of diabetic complications based on genomic signatures. It offers biomarkers and genomic markers for type 2 diabetes (T2D). The company’s products include PGX IR01, an in vitro molecular predictive test for assessing the risk of complications in patients with T2D; and PGx GR01, an in vitro molecular screening test for the selection of diabetic patients at higher risk of cardiovascular events. Its products also include PGx CD01, an in vitro molecular companion diagnostic product for the prevention of cardiovascular and renal complications of T2D; and PGx IR02, an individual risk pro...

4101, rue Molson

bureau 201

Montreal, QC H1Y 3L1

Canada

Founded in 2005

Phone:

514-529-9757

Fax:

514-529-0113

Key Executives for Prognomix, Inc.

Chief Executive Officer
Founder
Secretary of the Board
Senior Director
Compensation as of Fiscal Year 2014.

Similar Private Companies By Industry

Company Name Region
Clementia Pharmaceuticals, Inc. Americas
Endoceutics, Inc. Americas
Mikro-Tek, Inc. Americas
BioCurex Inc. Americas
Milestone Pharmaceuticals Inc. Americas

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
NYC2012, Inc. United States
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Rush University United States
Greater Houston Partnership United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Prognomix, Inc., please visit www.prognomix.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.